DongKookPharmaceuticalCo

동국제약 · 086450

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$607M (₩837.7B)

Overview

DongKook Pharmaceutical makes medicines and health-care products supplied to patients and healthcare providers in South Korea.

The company is listed on KOSDAQ, South Korea's technology and small-cap stock exchange. Because the filing excerpt provided covers only a table of contents rather than detailed business descriptions, only a general characterisation of its pharmaceutical operations can be confirmed.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$671.7M

▲ +14.1% YoY

Operating profit · FY2025

US$70M

▲ +20.1% YoY

Net income · FY2025

US$53.6M

▲ +18.6% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$529.7M(₩731B)	US$588.5M(₩812.2B)	US$671.7M(₩926.9B)
Operating profit	US$48.5M(₩66.9B)	US$58.3M(₩80.4B)	US$70M(₩96.6B)
Net income	US$35.4M(₩48.9B)	US$45.2M(₩62.3B)	US$53.6M(₩73.9B)

Revenue

FY2023US$529.7M
FY2024US$588.5M
FY2025US$671.7M

Operating profit

FY2023US$48.5M
FY2024US$58.3M
FY2025US$70M

Net income

FY2023US$35.4M
FY2024US$45.2M
FY2025US$53.6M

Key ratios (FY2025)

ROE

9.7%

Debt/Eq

39.2%

Op. margin

10.4%

Net margin

8.0%

Rev. YoY

▲ +14.1%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?